Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 61, Issue 15, Pages 6869-6891Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.8b00808
Keywords
-
Categories
Ask authors/readers for more resources
EP2 receptor agonists are expected to be effective ocular hypotensive agents; however, it has been suggested that agonism to other EP receptor subtypes may lead to undesirable effects. Through medicinal chemistry efforts, we identified a scaffold bearing a (pyridin-2-ylamino)-acetic acid moiety as a promising EP2-selective receptor agonist. (64(4-(Pyrazol-1-yl)benzyl)(pyridin-3-ylsulfonyl)-aminomethyppyridin-2-ylamino)acetic acid 13ax (omidenepag, OMD) exerted potent and selective human EP2 receptor (h-EP2). Low doses of omidenepag isopropyl (OMDI), a prodrug of 13ax, lowered (IOP) in ocular normotensive monkeys. OMDI was selected as a clinical candidate for the treatment of glaucoma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available